Non-members: Click here to review a complimentary excerpt from "Supporting Successful Product Launches: Tactics for Educating Payers"
Effective payer education of new products has become paramount in the face of the ever-growing role of the payer and government sectors in the marketplace. Specifically, the competitive marketplace necessitates that payers are not only well educated in the benefits of the therapies but also how the products are different from existing treatments. This Best Practices, LLC study delivers benchmarks around timing of education tactics for payers and identifies the most important edcation activities for payers. Additionally, this study contains qualitative insights from industry executives regarding methods for effectively communicating with payers. Executives can use this research to compare their strategies and tactics with those of leading organizations.
- Summary of Key Insights, Findings and Lessons Learned
- Research Participants, Launch Experience, and Therapeutic Area Demographics
- Post-Approval Early Access Programs: Getting to First Reimbursed Prescription Quickly
- Payer Education Starts Early: Focus on Cost and Outcomes
- Voices From the Field: Best Practices, Lessons Learned & Pitfalls
- Future Trends & Issues
Sample Key Metrics
- Timing of Education Activities for Payers and Government Entities
- Top Five Education Activities for Payers and Government Entities
- Mix of Market Education Investment
Sample Key Findings
Winning Payers On Board: Commence work earlier than in past to win payers. Focus on cost and health outcomes. Understand payer needs and engineer them increasingly into clinical trials.
Research was conducted through surveys and interviews. Research participants included 34 executives and managers from 26 leading pharmaceutical, biotech and medical device companies. In addition, nine interviews were conducted with selected participants.